Clin2
NCT06749483Likely a fitRecruiting

Gut bacteria and infection in intensive care patients

Critical IllnessIntensive Care Unit DeliriumNeurocognitive DeficitMicrobiome,immune Function, Critically IllInfection in ICUSepsis

Part of Brain & nervous system, Infections, Mental health clinical trials.

This study looks at how gut bacteria affect severe infections in the ICU. It tests whether the microbiome can be a source of sepsis and a target for treatment. If you are critically ill or a long-term sepsis survivor, you might help find new ways to prevent infections.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You are either a critically ill patient starting certain antibiotics in the last 3 days, a critically ill patient without recent antibiotics who will likely stay in the ICU for more than 3 days, or a long-term survivor of sepsis from a previous study.
  • You do not have inflammatory bowel disease (like Crohn's or ulcerative colitis).
  • You have not had a major bowel resection (removal of a large part of the intestines).
  • You are not immunocompromised (weakened immune system).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07864818Not yet recruiting
Gut bacteria study for sepsis patients in the ICU

This study looks at the bacteria in the gut of patients with sepsis in the ICU. It aims to understand how these bacteria change during critical illness, which could lead to better treatments.

Wuhan, Hubei
NCT07345169Recruiting
Immune and inflammation study in ICU patients

This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.

Paris
NCT07813507Not yet recruiting· Phase 1/Phase 2
Gut microbiome treatment for adults on breathing machines in ICU

This study tests a treatment that changes the gut bacteria of adults in the ICU who need a breathing machine. The goal is to see if it helps prevent harmful germs from growing in the gut, which might lead to better recovery.

Calgary, Alberta
NCT07295353Not yet recruiting
Gut supplement to boost recovery after ICU stay

This trial tests a supplement made from a natural gut bacterium (Akkermansia muciniphila) to see if it helps you recover faster after being in the ICU with sepsis. The supplement is taken by mouth after you leave the ICU.

NCT07735182Recruiting
Gut bacteria and organ damage in sepsis

This study looks at how bacteria in your gut and other signs in your body affect liver and kidney damage in people with sepsis. It also compares findings to healthy volunteers to see what is different.

Hangzhou, Zhejiang
NCT07353970Not yet recruiting
Severe infection and sepsis study

This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.

Hear when a new Critical Illness trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.